• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS.

作者信息

Lo Coco Daniele, Veglianese Pietro, Allievi Elisa, Bendotti Caterina

机构信息

Lab. Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy.

出版信息

Neurosci Lett. 2007 Jan 22;412(1):73-7. doi: 10.1016/j.neulet.2006.10.063. Epub 2006 Dec 15.

DOI:10.1016/j.neulet.2006.10.063
PMID:17196331
Abstract

Although the aetiology of amyotrophic lateral sclerosis (ALS) is still elusive, increased attention has been put forward on events related to neuroinflammation and an active participation of glial cells in the ALS pathogenesis has been suggested. However, the specific role of many proinflammatory mediators that usually accompany the inflammatory changes is still largely unknown. High mobility group box protein 1 (HMGB1) is an ubiquitous nuclear protein that exerts numerous extranuclear and extracellular functions, including a proinflammatory activity, able to induce cytokines expression and activate inflammatory cells. To investigate whether this protein may play a role in the inflammatory events in ALS, we examined both expression and localization of HMGB1 in the lumbar spinal cord of SOD1G93A transgenic mice, a well established mouse model of familial ALS, at different stages of the disease. Intense HMGB1 reactivity was detected in ventral horn motor neurons of both non-transgenic and SOD1G93A mice and there was no difference in its expression between presymptomatic SOD1G93A mice and controls. With the progression of the disease, degenerating neurons showed a reduction of HMGB1 immunoreactivity which could reflect an extracellular release of this protein. By contrast, in the reactive glial cells HMGB1 was remarkably expressed in the nucleus, but not in the cytosol, likely contributing to the proliferation and/or hypertrophy of these cells. These results suggest that HMGB1 may have a different involvement in the motor neurons and glial cells in response to the neurotoxic environment in the spinal cord of SOD1G93A mice, and it may contribute to the progression of inflammatory and neurodegenerative processes.

摘要

相似文献

1
Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS.
Neurosci Lett. 2007 Jan 22;412(1):73-7. doi: 10.1016/j.neulet.2006.10.063. Epub 2006 Dec 15.
2
Kif1Bbeta isoform is enriched in motor neurons but does not change in a mouse model of amyotrophic lateral sclerosis.Kif1Bbeta 亚型在运动神经元中富集,但在肌萎缩侧索硬化症小鼠模型中无变化。
J Neurosci Res. 2003 Mar 1;71(5):732-9. doi: 10.1002/jnr.10517.
3
Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.在肌萎缩侧索硬化症的人超氧化物歧化酶1 G93A小鼠模型中,Toll样受体4(TLR4)的缺失可延长生存期。
J Neuroinflammation. 2015 May 13;12:90. doi: 10.1186/s12974-015-0310-z.
4
Dysregulation of Steroid Hormone Receptors in Motor Neurons and Glia Associates with Disease Progression in ALS Mice.运动神经元和神经胶质中类固醇激素受体的失调与 ALS 小鼠疾病进展相关。
Endocrinology. 2020 Sep 1;161(9). doi: 10.1210/endocr/bqaa113.
5
Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue.Toll 样受体信号通路在肌萎缩侧索硬化症脊髓组织中的作用。
Neuroscience. 2011 Apr 14;179:233-43. doi: 10.1016/j.neuroscience.2011.02.001. Epub 2011 Feb 12.
6
Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1 mouse model of amyotrophic lateral sclerosis.HMGB1 的治疗性阻断可减少运动功能障碍,但不能改善 SOD1 肌萎缩侧索硬化症小鼠模型的存活。
J Neuroinflammation. 2019 Feb 19;16(1):45. doi: 10.1186/s12974-019-1435-2.
7
Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis.家族性肌萎缩侧索硬化小鼠模型脊髓运动神经元中PI3K/AKT生存通路无变化。
Mol Cell Neurosci. 2007 Apr;34(4):592-602. doi: 10.1016/j.mcn.2007.01.003. Epub 2007 Jan 11.
8
Reduction of cytosolic phospholipase A2α upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis.降低胞质磷脂酶A2α的上调可延缓肌萎缩侧索硬化症SOD1G93A小鼠模型症状的出现。
J Neuroinflammation. 2016 Jun 1;13(1):134. doi: 10.1186/s12974-016-0602-y.
9
Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice.Wnt/β-连环蛋白信号通路的激活与 ALS 转基因小鼠成年脊髓中的神经胶质细胞增殖有关。
Biochem Biophys Res Commun. 2012 Apr 6;420(2):397-403. doi: 10.1016/j.bbrc.2012.03.006. Epub 2012 Mar 9.
10
Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.肌萎缩侧索硬化转基因小鼠中组织蛋白酶D和半胱氨酸蛋白酶抑制剂的分布及水平改变:对运动神经元存活的可能作用
Neuroscience. 2006 Dec 1;143(2):419-30. doi: 10.1016/j.neuroscience.2006.07.048. Epub 2006 Sep 14.

引用本文的文献

1
Review: The role of HMGB1 in spinal cord injury.综述:HMGB1 在脊髓损伤中的作用。
Front Immunol. 2023 Jan 12;13:1094925. doi: 10.3389/fimmu.2022.1094925. eCollection 2022.
2
HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target.高迁移率族蛋白B1在神经系统疾病中的作用:一种常见的生物标志物和潜在的治疗靶点。
Front Neurol. 2022 Oct 31;13:1029891. doi: 10.3389/fneur.2022.1029891. eCollection 2022.
3
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.
晚期糖基化终产物受体(RAGE):针对神经退行性疾病治疗的有前途的靶点。
Curr Neuropharmacol. 2023;21(2):219-234. doi: 10.2174/1570159X20666220922153903.
4
Role of RAGE in the Pathogenesis of Neurological Disorders.晚期糖基化终产物受体(RAGE)在神经退行性疾病发病机制中的作用。
Neurosci Bull. 2022 Oct;38(10):1248-1262. doi: 10.1007/s12264-022-00878-x. Epub 2022 Jun 21.
5
The mechanism of HMGB1 secretion and release.HMGB1分泌与释放的机制。
Exp Mol Med. 2022 Feb;54(2):91-102. doi: 10.1038/s12276-022-00736-w. Epub 2022 Feb 25.
6
The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review.高迁移率族蛋白 B1(HMGB1)在神经退行性变中的作用:系统评价。
Curr Neuropharmacol. 2022;20(11):2221-2245. doi: 10.2174/1570159X20666220114153308.
7
Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review.基于抗体的肌萎缩侧索硬化症治疗干预:系统文献综述
Front Neurosci. 2021 Nov 29;15:790114. doi: 10.3389/fnins.2021.790114. eCollection 2021.
8
The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies.神经血栓炎症在神经退行性疾病和神经创伤中的不断演变的概念:PAR1 靶向治疗的理由。
Biomolecules. 2021 Oct 21;11(11):1558. doi: 10.3390/biom11111558.
9
Long noncoding RNA BS-DRL1 modulates the DNA damage response and genome stability by interacting with HMGB1 in neurons.长非编码 RNA BS-DRL1 通过与神经元中的 HMGB1 相互作用调节 DNA 损伤反应和基因组稳定性。
Nat Commun. 2021 Jul 1;12(1):4075. doi: 10.1038/s41467-021-24236-z.
10
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.免疫与肌萎缩侧索硬化症的相互作用:临床影响。
Neurosci Biobehav Rev. 2021 Aug;127:958-978. doi: 10.1016/j.neubiorev.2021.06.027. Epub 2021 Jun 19.